申请人:AstraZeneca AB
公开号:US06265415B1
公开(公告)日:2001-07-24
The present invention relates to imidazo pyridine derivatives of the formula (I), in which the phenyl moiety is substituted with lower alkyl in 2- and 6-position, which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases.
本发明涉及式(I)的咪唑吡啶衍生物,其中苯基部分在2-和6-位置被较低的烷基取代,它们抑制外源性或内源性刺激的胃酸分泌,因此可用于预防和治疗胃肠道炎症性疾病。